Typhoid conjugate vaccine: are we heading towards the elimination of typhoid in endemic countries?

MT Yousafzai, AE Heywood - The Lancet Global Health, 2022 - thelancet.com
Typhoid fever caused by Salmonella enterica serovar Typhi (S Typhi) is a serious public
health problem in low-income and middle-income countries (LMIC). Globally about 11 …

Typhoid conjugate vaccines: a step towards typhoid control

M Shakya, AJ Pollard - The Lancet Global Health, 2024 - thelancet.com
Rabab Batool and colleagues1 report the efficacy and safety of typhoid vaccines in
preventing cultureconfirmed SalmonellaTyphi infections using a systematic review and meta …

High burden of typhoid disease in sub-Saharan Africa calls for urgent roll-out of typhoid conjugate vaccines

S Kariuki, RS Onsare - The Lancet Global Health, 2024 - thelancet.com
By 2019, there were an estimated 9· 24 million cases of typhoid fever and 110 000 deaths
globally, with the greatest burden being in low-income and middleincome countries in sub …

Long-term protection conferred by typhoid conjugate vaccines: a step towards typhoid elimination?

BT Tadesse, RSB Cardona, F Marks - The Lancet, 2024 - thelancet.com
The global burden of typhoid fever remains substantial, with an estimated 9· 24 million cases
and 110 000 deaths in 2019, with the majority of these infections and deaths occuring in the …

Use of the typhoid conjugate vaccine in endemic settings

F Khanam, F Qadri - The Lancet Global Health, 2021 - thelancet.com
Multidrug-resistant and extensively drug-resistant (XDR) strains of Salmonella enterica
serotype Typhi (S Typhi) are increasingly creating serious clinical and economic challenges …

Tackling typhoid fever in South Asia: lessons from Vietnam

B Basnyat, A Karkey - The Lancet Global Health, 2019 - thelancet.com
Biblical diseases like typhoid fever continue to plague South Asia, a densely populated
region of 1· 8 billion people. Typhoid fever, also known as enteric fever, comprises both …

Vi-TT—a typhoid conjugate vaccine for infants and young children

TF Wierzba, AK Shetty - The Lancet Global Health, 2021 - thelancet.com
Salmonella enterica serovar Typhi (S Typhi) is the causative agent of typhoid fever. Globally,
typhoid fever affected 9· 24 million people and caused 110 000 deaths in 2019, primarily in …

The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection

Y Jo, DW Dowdy - The Lancet Infectious Diseases, 2019 - thelancet.com
Typhoid fever affects an estimated 11–20 million people globally, causing 128 000–161 000
deaths per year, many of which occur in young children living in resource-limited settings. 1 …

Are we adequately prepared for the emergence of Salmonella enterica serovar Paratyphi A?

S Baker, A Karkey, C Parry - The Lancet Global Health, 2014 - thelancet.com
Typhoid fever is a life-threatening systemic disease caused by the bacterium Salmonella
enterica serovar Typhi (S Typhi). Years of focused research have resulted in a detailed, but …

Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance

JR Andrews, S Baker, F Marks, M Alsan… - The Lancet Infectious …, 2019 - thelancet.com
Typhoid fever is an acute systemic infectious disease responsible for an estimated 12–20
million illnesses and over 150 000 deaths annually. In March, 2018, a new recommendation …